Reference | ||
---|---|---|
Reference Type | Literature | IEDB_Reference:1001817 |
Title | CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. | |
Authors | Angus J MacDonald; Margaret Duffy; Miriam T Brady; Susan McKiernan; William Hall; John Hegarty; Michael Curry; Kingston H G Mills | |
Affiliations | Immune Regulation Research Group, Department of Biochemistry, Trinity College Dublin, Ireland. | |
Journal | J Infect Dis | |
Year | 2002 | |
Abstract | The factors that determine persistence or clearance of hepatitis C virus (HCV) infection are poorly understood. The CD4 T cell responses to the HCV core protein were examined in a cohort of women infected with a single genotype of HCV. CD4 T cells from HCV-infected patients secreted interferon (IFN)-gamma in response to peptides from 4 immunodominant regions of the core protein, and these responses were stronger in persistently infected women. Interleukin (IL)-10 was also produced by CD4 T cells from HCV-infected subjects in response to the same core peptides. Furthermore, HCV core-specific CD4 T cell clones secreted either IFN-gamma or IL-10 but not IL-4. These findings demonstrate that T helper type 1 and regulatory T cells are induced against the same epitopes on the core protein during HCV infection. | |
Curation Last Updated | 2023-08-18 20:11:58 |
Epitope | ||
---|---|---|
Epitope ID | 717 | IEDB_epitope:717 |
Chemical Type | Linear peptide | |
Linear Sequence | ADLMGYIPLVGAPLGGAARA | |
Source Molecule Name | polyprotein | |
Source Organism | Hepatitis C virus subtype 1b (Hepatitis C virus type 1b) | |
Starting Position | 131 | |
Ending Position | 150 |
Epitope Reference Details | ||
---|---|---|
Epitope Structure Defines | Epitope containing region/antigenic site | |
Epitope Name | Core 131-150 | |
Reference Starting Position | 131 | |
Reference Ending Position | 150 | |
Location of Data in Reference | Figure 1 |
Immunization | ||
---|---|---|
Host Organism | Homo sapiens (human) |
Host Details | ||
---|---|---|
Sex | F | |
Age | 41-55 | |
MHC Types present | HLA-DRB1*07:01;HLA-DQB1*05:01;HLA-DRB1*01:01;HLA-DQB1*02:01 |
1st In Vivo Process | ||
---|---|---|
In Vivo Process Type | Occurrence of infectious disease | |
Disease State | hepatitis C | |
Disease Stage | Chronic; | OGMS:0000064 |
1st Immunogen | ||
---|---|---|
Epitope Relation | Source Organism | |
Object Type | Organism | |
Organism | Hepatitis C virus subtype 1b (Hepatitis C virus type 1b) |
Immunogen Details | ||
---|---|---|
Immunogen Reference Name | Hepatitis C virus subtype 1b |
Immunization Comments | ||
---|---|---|
Immunization Comments | PBMC were harvested from a group of Irish women infected with HCV 1b through the administration of contaminated anti-D Ig. |
T Cell Assay | ||
---|---|---|
Qualitative Measurement | Positive | |
Method/Technique | ELISA | |
Measurement of | IFNg release |
Effector Cells | ||
---|---|---|
Effector Cell Tissue Type | Blood | |
Effector Cell Type | PBMC | |
Effector Cell Culture Conditions | Direct Ex Vivo |
Antigen Presenting Cells | ||
---|---|---|
Cell Tissue Type | Blood | |
Cell Type | PBMC | |
Cell Culture Conditions | Direct Ex Vivo |
Antigen | ||
---|---|---|
Epitope Relation | Epitope | |
Chemical Type | Linear peptide | |
Linear Sequence | ADLMGYIPLVGAPLGGAARA | |
Source Molecule Name | polyprotein | |
Source Organism | Hepatitis C virus subtype 1b (Hepatitis C virus type 1b) | |
Starting Position | 131 | |
Ending Position | 150 |
Antigen Details | ||
---|---|---|
Antigen Reference Name | Core 131-150 |
Assay Reference Details | ||
---|---|---|
Assay Comments by IEDB Curator | PBMC from HCV infected patients produced IFNg in response to the epitope. Chronically infected patients (HCV PCR+) responded more often than patients who cleared the virus (HCV RNA-). | |
Location of Assay Data in Reference | Figure 2 and table 1 |